ViRexx Medical Corp. (TSX:VIR) (AMEX: REX), a company focused on immunotherapy treatments for certain cancers, chronic hepatitis B & C and embolotherapy treatments for tumors, today announced that Dr. Lorne Tyrrell, Ph.D. M.D., Chief Executive Officer and Chief Scientific Officer, will give a presentation entitled, Duck Hepatitis B Virus Model and Assessment of Antiviral Therapy, at the Management of Chronic Hepatitis B Virus: 2006 Meeting at 2:20 pm on April 6th at the Natcher Conference Center, National Institute Health Campus in Bethesda, Maryland.
